AstraZeneca EVUSHELD Named on TIME’s List of the Best Inventions of 2022
WILMINGTON, Del.–(BUSINESS WIRE)–Today, TIME named AstraZeneca’s EVUSHELD (tixagevimab co-packaged with cilgavimab) on their 2022 list of Best Inventions. Their selection of EVUSHELD reflects its impact as the first and only long-acting monoclonal antibody to receive emergency use authorization in the US for the prevention of COVID-19 in immunocompromised people. “Immunocompromised individuals have lived a very … [Read more…]